Hormone Replacement Therapy Safe For Women With Menopause & Cancer Survivors

Main Category: Menopause
Also Included In: Cancer / Oncology
Article Date: 29 Jun 2005 - 0:00 PDT

email to a friend   printer friendly   opinions  

Research shows that short-term hormone replacement therapy (HRT) is appropriate for peri- and postmenopausal women. These and other results from the Women's Health Initiative (WHI), the largest, most statistically valid and well analyzed research evaluating the use of HRT, are reviewed in the International Journal of Gynecological Cancer.

In peri- and postmenopausal women who have moderate to severe vasomotor symptoms associated with estrogen deficiency, data shows that HRT can be beneficial. Although the WHI results only provided data from an oral continuous therapy, researchers say that other routes may be safer and patients should discuss the option with their doctor to weigh the risks against severity of symptoms and expected benefits.

Additionally, several studies have shown that the use of HRT in patients who are survivors from gynecologic cancer does not compromise survival, as was previously thought. Several retrospective studies have failed to demonstrate an adverse effect and the establishment of a definitive role for HRT will depend on the analysis of randomized clinical trials.

This study is published in the latest issue of the International Journal of Gynecological Cancer. Media wishing to receive a PDF of the article please contact medicalnews@bos.blackwellpublishing.net.

Corresponding author Vera Loizzi, MD, is a clinical instructor in the Department of Obstetrics and Gynecology at the University of Bari, Italy.

About the International Journal of Gynecological Cancer<.b>

International Journal of Gynecological Cancer presents papers from throughout the global community of researchers covering many topics including basic science, epidemiology, diagnostic techniques, surgery, radiotherapy, chemotherapy, pathology and experimental studies, The Journal allows you to call on a roster of international experts for the latest research, advice, and knowledge in order to provide the best treatment for your patients.

About Blackwell Publishing<.b>

Blackwell Publishing is the world's leading society publisher, partnering with more than 600 academic and professional societies. Blackwell publishes over 750 journals and 600 text and reference books annually, across a wide range of academic, medical, and professional subjects.

Sharon Agsalda
medicalnews@bos.blackwellpublishing.net
781-388-8507
Blackwell Publishing Ltd.
http://www.blackwellpublishing.com

• Additional
• References
• Citations

Article adapted by Medical News Today from original press release.
Visit our menopause section for the latest news on this subject.

There are no references listed for this article.

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Sharon Agsalda. "Hormone Replacement Therapy Safe For Women With Menopause & Cancer Survivors." Medical News Today. MediLexicon, Intl., 29 Jun. 2005. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/26758.php>

---

APA

Sharon Agsalda. (2005, June 29). "Hormone Replacement Therapy Safe For Women With Menopause & Cancer Survivors." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/26758.php.

---

Please note: If no author information is provided, the source is cited instead.